Assayed, cold-chained, and dispatched from our Sydney facility with the manufacturer-supplied Certificate of Analysis.
Tirzepatide 30mg
Research Compound | 30mg Vial Product Overview Tirzepatide is a synthetic peptide compound that acts as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It has been the subject of extensive scientific research examining incretin signalling pathways, metabolic regulation and glucose homeostasis.
- Dosage
- 30mg
- Purity
- 99%
- Lot No.
- TBD
- Storage
- 2–8°C · Refrigerated
- Category
- glp-research
- Use
- Research only · not for human consumption
Background
Research Background Tirzepatide interacts with two key incretin hormone receptor pathways: GIP receptor: Involved in glucose-dependent insulin secretion and metabolic signalling. GLP-1 receptor: Associated with glucose regulation, insulin secretion and appetite-related signalling. The dual-receptor activity makes Tirzepatide an important subject in metabolic and endocrinology research.
Storage & Reconstitution
Store lyophilised vials at 2–8°C. After reconstitution with bacteriostatic water, store at 2–8°C and use within 28 days.
Customer Reviews
FAQ
Related Products
RT10
Triple-agonist GLP-1 / GIP / glucagon research peptide.
KLOW 80mg
KLOW 80mg — A proprietary research blend combining BPC-157, GHK-Cu, KPV and TB-500, formulated for laboratory research into tissue repair, inflammation, cellular signalling and regenerative pathways.
RT20
High-dose triple-agonist research peptide. Purple Cap